Literature DB >> 8877256

A factorial survey study to assess the acceptability of HIV vaccine trial designs.

M Hennessy1, K MacQueen, D J McKirnan, S Buchbinder, F Judson, J M Douglas, B Bartholow, A Sheon.   

Abstract

To aid in the design of human immunodeficiency virus (HIV) vaccine trials that maximize volunteer participation, factorial surveys were administered to 73 gay men who were participants in a larger study assessing HIV vaccine trial feasibility. Factorial surveys are "vignettes" that are randomly constructed through the combination of descriptive statements (dimensions) that reflect essential features. In this study, the dimensions define components of clinical trials to assess the efficacy of hypothetical HIV vaccines. Regression analysis shows that anticipated participation was decreased by a sustained vaccine-induced antibody response lasting 3 years, absence of gay men as research subjects in earlier phase trials for the products being tested, and rectal vaccine administration. Three years of scientific experience with the vaccine encouraged participation. We conclude that willingness to participate in vaccine trials varies systematically with some of their characteristics. Where there are design alternatives for identified negative components, these should be considered. If this is not possible, options for decreasing aversion to such features will need to be evaluated, including appropriate education regarding both the benefits and the risks associated with negatively evaluated features.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877256     DOI: 10.1016/0197-2456(95)00155-7

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  8 in total

1.  Evaluating the risk and attractiveness of romantic partners when confronted with contradictory cues.

Authors:  Michael Hennessy; Martin Fishbein; Brenda Curtis; Daniel W Barrett
Journal:  AIDS Behav       Date:  2007-05

2.  Confirming preferences or collecting data? Information search strategies and romantic partner selection.

Authors:  Michael H Hennessy; Marty Fishbein; Brenda Curtis; Daniel Barrett
Journal:  Psychol Health Med       Date:  2008-03       Impact factor: 2.423

3.  Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.

Authors:  William Domm; Lauren Brooks; Hung Li Chung; Changyong Feng; William J Bowers; Gene Watson; James L McGrath; Stephen Dewhurst
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

4.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.

Authors:  Paula M Frew; Mark J Mulligan; Su-I Hou; Kayshin Chan; Carlos del Rio
Journal:  Open Access J Clin Trials       Date:  2010-09-01

5.  Factors influencing HIV vaccine community engagement in the urban South.

Authors:  Paula M Frew; Carlos del Rio; Sarah Clifton; Matthew Archibald; Joseph T Hormes; Mark J Mulligan
Journal:  J Community Health       Date:  2008-08

6.  In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

Authors:  Paula M Frew; Wendy Macias; Kayshin Chan; Ashley C Harding
Journal:  J Health Mass Commun       Date:  2009

7.  Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP.

Authors:  Amy Corneli; Samuel Field; Emily Namey; Kawango Agot; Khatija Ahmed; Jacob Odhiambo; Joseph Skhosana; Greg Guest
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

8.  Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.

Authors:  Suzanne Day; Meredith Blumberg; Thi Vu; Yang Zhao; Stuart Rennie; Joseph D Tucker
Journal:  J Int AIDS Soc       Date:  2018-10       Impact factor: 5.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.